A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/04 (2006.01) A61K 31/7042 (2006.01) A61P 31/12 (2006.01) C07D 309/10 (2006.01)
Patent
CA 2527989
The invention provides methods for preventing, treating, managing or ameliorating viral infections, in particular, Severe Acute Respiratory Syndrome (SARS). More specifically, the invention provides methods for preventing, treating, managing or ameliorating a SARS-associated coronavirus or one or more symptoms thereof by administering Glycyrrhizin and/or derivatives thereof The invention also provides methods for preventing, treating, managing or ameliorating a SARS-associated coronavirus or one or more symptoms thereof by administering Glycyrrhizin and/or a derivative thereof in combination with a prophylactic or therapeutic agent other than Glycyrrhizin or a derivative thereof.
La présente invention se rapporte à des procédés de prévention, de traitement, de gestion ou d'amélioration d'infections virales et notamment du syndrome respiratoire aigu sévère (SRAS). Plus précisément, l'invention se rapporte à des procédés de prévention, de traitement, de gestion ou d'amélioration d'un coronavirus associé au SRAS ou à un ou plusieurs de ses symptômes, par administration de glycyrrhizine et/ou de l'un de ses dérivés en association avec un agent prophylactique ou thérapeutique autre que la glycyrrhizine et/ou l'un de ses dérivés.
Cinatl Jindrich
Doerr Hans Wilhelm
Hover Gerold
Michaelis Martin
Johann Wolfgang Goethe University
Ridout & Maybee Llp
LandOfFree
Glycyrrhizin or derivatives thereof for treating or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycyrrhizin or derivatives thereof for treating or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycyrrhizin or derivatives thereof for treating or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1952213